The Fund supports several networks of state health policymakers to help identify, inspire, and inform policy leaders.
The Milbank Memorial Fund supports two state leadership programs for legislative and executive branch state government officials committed to improving population health.
The Fund identifies and shares policy ideas and analysis on topics important to state health policymakers, particularly on issues related to state leadership, primary care, aging, and health care costs.
Keep up with news and updates from the Milbank Memorial Fund. And read the latest blogs from our thought leaders, including Fund President Christopher F. Koller.
The Fund publishes The Milbank Quarterly, as well as reports, issues briefs, and case studies on topics important to health policy leaders.
The Milbank Memorial Fund is is a nonpartisan foundation focused on improving the health of communities and entire populations.
Christine Haran Communications Director 917-216-5359 charan@milbank.org
The Milbank Memorial Fund is an endowed operating foundation that aims to improve population health by connecting leaders and decision makers with the best available evidence and experience. It does this work by:
A health system based on high-quality primary care leads to better health outcomes and better health equity. No other part of the health system can… More
The Milbank Memorial Fund announced today that Connecticut, Oregon, Nevada, New Jersey, and Washington have been selected to participate in the Peterson-Milbank Program for Sustainable Health Care Costs. More
Yesterday’s events in Washington, DC, were a failure of elected leadership and public citizenry. Such violence must not be tolerated or… More
Building Back Better is a new series offering policy recommendations for the Biden administration throughout the transition period authored by members of the Quarterly’s Editorial Advisory Board. More
In a December 28, 2020, Boston Globe Opinion Milbank Memorial Fund President Christopher F. Koller wrote that by investing in the nation’s primary care system, the incoming Biden administration can help control the pandemic — and improve health outcomes and reduce disparities in the process. More
The Peterson Center on Healthcare and the Milbank Memorial Fund have launched an initiative to provide technical assistance to up to five states to help reduce health spending. More
Delaware, New Jersey, and Rhode Island announced last week a commitment to a common framework for COVID-19 testing for high-risk, asymptomatic residents and for financing this testing. More
Read more
Milbank Memorial Fund Experts
Milbank Memorial Fund staff have expertise in state health policy leadership, primary care investment and transformation, approaches to containing health care costs, and more.
Read Bio
Milbank Quarterly Experts
Our editor and contributors offer innovative thinking about public heath and health policy.
See All Experts
Download
Well-designed state merger review authority can prevent further health provider consolidation and offer better oversight of approved transactions. A new brief from @SourceOnHealth explains the 4 main components of comprehensive state merger review. https://buff.ly/3yriOx3
President Biden’s executive order on competition takes an aggressive approach to hospital consolidation & mobilizes federal agencies to work independently & collectively, say @SourceOnHealth experts in a new blog. States can also leverage this opportunity https://buff.ly/3xqjIJ3
Medical #language education represents a largely untapped opportunity to improve health equity. Here are just a few recommendations for language-appropriate health policy via @Health_Affairs. https://bit.ly/3jiSZZI
A study by authors at @CSPI, @umichsph & @HarvardChanSPH finds that the removal of #transfats from the US food supply chain was driven by a policy and systems approach that ultimately did not require individual behavior change https://buff.ly/3CiA1e
Public health officials have long urged health professionals and policymakers to take a more holistic approach to health care, but what ethical questions does social prescribing pose? @UniofOxford researchers explore this question in a study of @NHSuk https://buff.ly/2TSWQ79
Pharmaceutical companies routinely cover the cost of patient copays for expensive drugs under private insurance. A federal judge could make the practice legal for millions on Medicare as well. 📝: @jayhancock1 https://khn.org/news/article/pfizer-court-fight-could-legalize-medicare-copays-and-unleash-gold-rush-in-sales/
